PROYECTO DE BIOMEDICINA CIMA, S.L.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Sep 13, 2016 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 193 Total Citation Count
- May 13, 1999 Earliest Filing
- 43 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0074,475 CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDSNov 20, 15Mar 17, 16[A61K, C07K]
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0056,943 IMMUNO-STIMULANT COMBINATION FOR PROPHYLAXIS AND TREATMENT OF HEPATITIS CAbandonedSep 27, 13Feb 27, 14[A61K]
8541370 Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatmentsExpiredAug 23, 10Sep 24, 13[A61K]
2013/0064,790 PEPTIDES WITH THE CAPACITY TO BIND TO INTERLEUKIN-10 (IL-10)AbandonedMar 08, 12Mar 14, 13[A61K, C12P, C12N, A61P, C07K]
2012/0315,256 USE OF TRANSFORMING GROWTH FACTOR - BETA 1 (TGF-B1) INHIBITOR PEPTIDES FOR THE TREATMENT OF CORNEAL FIBROSIS AND/OR HAZEAbandonedFeb 21, 11Dec 13, 12[A61K, C07H, C12N, A61P, C07K]
2012/0308,517 COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND TUMOURAL DISEASESAbandonedFeb 07, 11Dec 06, 12[A61K, A61P]
2012/0237,535 Therapeutic Compositions For The Treatment of HPV-Induced DiseasesAbandonedSep 10, 10Sep 20, 12[A61K, C12N, A61P, C07K]
8257701 Methods for anti-fibrinolytic treatment using MMP-10 neutralizing antibodyExpiredJun 26, 08Sep 04, 12[A61K]
2012/0220,546 COMPOSTIONS DESIGNED FOR THE INHIBITION AND/OR BLOCKING OF THE EPITHELIAL/MESENCHYMAL TRANSITIONAbandonedMay 03, 12Aug 30, 12[A61K, C07H, A61P]
2012/0093,775 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSISAbandonedMar 26, 10Apr 19, 12[A61K, C12N, A61P]
8158589 Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)ExpiredFeb 22, 10Apr 17, 12[A61K]
2012/0083,464 NEUROPROTECTIVE PROPERTIES OF 5'-METHYLTHIOADENOSINEAbandonedJun 07, 10Apr 05, 12[A61K, A61P]
8148334 Peptides with capacity for binding with interleukine 10 (IL-10)ExpiredMar 27, 08Apr 03, 12[A61K, C12N, C07K]
2011/0293,557 CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDSAbandonedJun 12, 09Dec 01, 11[A61K, C07H, C12N, A61P, C07K]
2011/0293,562 USE OF CARDIOTROPHIN-1 FOR THE TREATMENT OF METABOLIC DISEASESAbandonedFeb 10, 10Dec 01, 11[A61K, A61P]
2011/0268,757 USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENTAbandonedDec 02, 09Nov 03, 11[A61K, C07H, C12N, A61P, C07K]
2011/0195,047 ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLSAbandonedOct 06, 09Aug 11, 11[A61K, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
